DEVELOPING AND VALIDATING COVID-19 ADVERSE OUTCOME RISK PREDICTION MODELS FROM A BI-NATIONAL EUROPEAN COHORT OF 5594 PATIENTS
Espen Jimenez‐Solem(University of Copenhagen), Martin Sillesen(Copenhagen University Hospital), Andreas D. Lauritzen(Gentofte Hospital), Marie Helleberg(Rigshospitalet), Anders Perner(Unknown), Martin Lillholm(University of Copenhagen), Marleen de Bruijne(University of Copenhagen), Mikkel Bonde(Copenhagen University Hospital), Mikkel Zöllner Ankarfeldt(Frederiksberg Hospital), Wouter Boomsma(University of Copenhagen), Alexander Bonde(Rigshospitalet), Tonny Studsgaard Petersen(Copenhagen University Hospital), Christian Igel(University of Copenhagen), Christina Lioma(University of Copenhagen), Benjamin Skov Kaas‐Hansen(Copenhagen University Hospital), Allan Linneberg(Frederiksberg Hospital), Mads Nielsen(University of Copenhagen), Matilde Winther‐Jensen(Jisc), Janne Petersen(University of Copenhagen), Gert Mehl Virenfeldt(Frederiksberg Hospital), Nicki Skafte Detlefsen(Technical University of Denmark), Raghavendra Selvan(University of Copenhagen), Bulat Ibragimov(University of Copenhagen), Stephan Sloth Lorenzen(University of Copenhagen), Oswin Krause(University of Copenhagen), Martin Erik Nyeland(Frederiksberg Hospital), Christian Hansen(University of Copenhagen), Jon Middleton(University of Copenhagen), Mostafa Mediphour Ghazi(University of Copenhagen), Jens Petersen(German Cancer Research Center), Akshay Pai(University of Copenhagen), Stine Mogensen(Danish Medicines Agency), Abraham George Smith(University of Copenhagen), Casper Hansen(University of Copenhagen), Hans‐Christian Thorsen‐Meyer(University of Copenhagen)
Cited by 8
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
|New England Journal of Medicine|2012|1.8k